Production (Stage)
GoodRx Holdings, Inc.
GDRX
$3.74
-$0.08-2.09%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 797.41M | 792.32M | 790.39M | 775.09M | 764.16M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 797.41M | 792.32M | 790.39M | 775.09M | 764.16M |
Cost of Revenue | 49.11M | 48.22M | 46.69M | 53.73M | 58.20M |
Gross Profit | 748.30M | 744.11M | 743.69M | 721.36M | 705.96M |
SG&A Expenses | 443.31M | 451.62M | 462.29M | 473.74M | 460.34M |
Depreciation & Amortization | 74.51M | 69.54M | 47.35M | 62.84M | 61.97M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 690.80M | 693.12M | 670.98M | 714.42M | 705.06M |
Operating Income | 106.61M | 99.20M | 119.41M | 60.67M | 59.10M |
Income Before Tax | 47.84M | 31.46M | -4.58M | -59.30M | -58.88M |
Income Tax Expenses | 19.38M | 15.07M | 11.64M | -618.00K | -52.29M |
Earnings from Continuing Operations | 28.45 | 16.39 | -16.22 | -58.68 | -6.59 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 28.45M | 16.39M | -16.22M | -58.68M | -6.59M |
EBIT | 106.61M | 99.20M | 119.41M | 60.67M | 59.10M |
EBITDA | 165.36M | 152.98M | 174.12M | 130.87M | 128.43M |
EPS Basic | 0.08 | 0.04 | -0.04 | -0.14 | -0.02 |
Normalized Basic EPS | 0.12 | 0.11 | 0.14 | 0.05 | 0.05 |
EPS Diluted | 0.07 | 0.04 | -0.04 | -0.14 | -0.02 |
Normalized Diluted EPS | 0.12 | 0.11 | 0.14 | 0.05 | 0.05 |
Average Basic Shares Outstanding | 1.52B | 1.53B | 1.55B | 1.58B | 1.62B |
Average Diluted Shares Outstanding | 1.54B | 1.55B | 1.57B | 1.59B | 1.62B |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |